High court denied interim relief to Merck

After the news that Novartis failed to secure an Indian patent for Glivec, the patenting woes of Western pharma in India seem to continue as Merck are denied interim relief in a patent case against Glenmark. The decision came within days of Merck’s subsidiary, MSD India, dragging the domestic company to court over the [...]

By |2017-09-07T15:11:06+05:30April 9th, 2013|Patent|0 Comments


India’s Supreme Court has set an important precedent in refusing to grant a patent to Novartis for an updated version of its cancer drug Glivec. The verdict will allow generic drug makers within the country to continue selling cheap versions of the drug, which is used to treat chronic myeloid leukemia and other cancers. [...]

By |2017-09-07T15:09:19+05:30April 7th, 2013|IP Basics, Patent|0 Comments

Ericsson sues micromax : Patent infringement

Every Morning in a Indian House starts with a cup of tea & a news on smartphone companies like HTC, Motorola, Apple fighting the patent wars, but it seems that the Smartphone patent war has been finally arrived in India too. Ericsson, world’s biggest telecom network equipment maker has recently filed a patent infringement [...]

By |2017-09-07T15:08:36+05:30April 7th, 2013|International, Patent|0 Comments


MNCs might have been waiting for this. After issuance of first compulsory license by Indian Patent Office to Natco from Bayer's for their drug Gleevac which is an anticancer drug, these MNC companies were already tensed that when some new generic company will rise up to the situation and file for compulsory license to [...]

By |2017-09-07T15:08:05+05:30March 21st, 2013|IP Basics|0 Comments
Go to Top